Abiopharma

🔍 Munsch Frederick (Executive)

Company: Bausch & Lomb Corp (BLCO)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Sold 52,900 shares of Common Shares, No Par Value at $16.78 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 45,831.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.73 to $16.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.